zinc sulphate is currently used for treatment of zinc deficiency. its uptake by the body is poor, necessitating the administration of high doses. this leads to a range of unpleasant side effects. in order to increase the bioavailability of zinc, several zinc complexes have been designed and synthesized using bidentate ligands of hydroxypyranones and hydroxypyridinones. elemental analysis in eac...

The synthesis of a range of novel 3-hydroxypyridin-4-ones and 3-hydroxypyran-4-ones linked with different coumarin substituents is described. These compounds have been developed in order to provide a series of molecular probes for the quantification of intracellular labile iron pools. An evaluation of the effect of iron(III) on fluorescence intensity was undertaken. Chelation of iron(III) cause...

Zinc sulphate is currently used for treatment of zinc deficiency. Its uptake by the body is poor, necessitating the administration of high doses. This leads to a range of unpleasant side effects. In order to increase the bioavailability of zinc, several zinc complexes have been designed and synthesized using bidentate ligands of hydroxypyranones and hydroxypyridinones. Elemental analysis in eac...

Zinc sulphate is currently used for treatment of zinc deficiency. Its uptake by the body is poor, necessitating the administration of high doses. This leads to a range of unpleasant side effects. In order to increase the bioavailability of zinc, several zinc complexes have been designed and synthesized using bidentate ligands of hydroxypyranones and hydroxypyridinones. Elemental analysis in eac...

The complex-forming ability of 2-methyl-3-hydroxypyran-4-one (1a), 2-ethyl-3-hydroxypyran-4-one (1b), 1,2-dimethyl-3-hydroxypyridin-4-one (4a) and 1-ethyl-2-methyl-3-hydroxypyridin-4-one (4b) with nickel(Ni(II)) were characterized by infrared, ultraviolet, proton nuclear magnetic resonance spectroscopy and melting point. The mole-ratio of nickel:ligands was analyzed by atomic-absorption-spectro...

the complex-forming ability of 2-methyl-3-hydroxypyran-4-one ( 1a ), 2-ethyl-3-hydroxypyran-4-one ( 1b ), 1,2-dimethyl-3-hydroxypyridin-4-one ( 4a ) and 1-ethyl-2-methyl-3-hydroxypyridin-4-one ( 4b ) with nickel(ni(ii)) were characterized by infrared, ultraviolet, proton nuclear magnetic resonance spectroscopy and melting point. the mole-ratio of nickel:ligands was analyzed by atomic-absorption...